Skip to main content

Table 1 Data were stratified according to the tertiles of serum total osteocalcin and presented as means ± SD or median (interquartile range) as appropriate

From: Association between osteocalcin, a pivotal marker of bone metabolism, and secretory function of islet beta cells and alpha cells in Chinese patients with type 2 diabetes mellitus: an observational study

 

T1

T2

T3

p

 

 < 14.02 ng/mL

14.02–19.78 ng/mL

 ≥ 19.78 ng/mL

 

n

67

68

69

 

Male/Female

47/20

51/17

42/27

0.194

Age (years)

55.84 ± 13.00

52.25 ± 14.57

56.61 ± 14.05

0.151

BMI (kg/m2)

26.03 (24.65,28.08)

25.97 (23.16,27.04)

25.97 (22.66,26.69)a

0.030*

Duration (years)

8.0 (2.00,13.00)

4.5 (1.16,12.00)

6.0 (2.00,12.00)

0.483

SBP (mmHg)

133.88 ± 12.59

132.10 ± 12.13

135.70 ± 14.58

0.281

DBP (mmHg)

78.97 ± 10.12

78.26 ± 9.67

24.73 ± 26.88

0.822

ALT (U/L)

28.85 ± 18.33

20.63 ± 11.12

24.73 ± 26.88

0.059

AST (U/L)

24.31 ± 18.64

18.91 ± 9.00

20.33 ± 11.45

0.060

UN (mmol/L)

5.88 ± 1.67

5.57 ± 1.11

5.90 ± 2.51

0.530

Cr (umol/L)

63.56 ± 19.73

58.45 ± 12.72

63.36 ± 23.92

0.222

SUA (umol/L)

340.91 ± 104.92

299.08 ± 76.35b

319.68 ± 106.15

0.045*

TC (mmol/L)

4.51 ± 1.44

4.97 ± 1.10

4.73 ± 1.05

0.091

TG (mmol/L)

2.30 ± 2.38

1.97 ± 1.66

2.04 ± 1.70

0.581

HDL (mmol/L)

1.02 ± 0.27

1.07 ± 0.24

1.03 ± 0.24

0.564

LDL (mmol/L)

2.64 ± 0.98

2.67 ± 0.74

2.65 ± 0.84

0.974

HbA1C (%)

8.65 ± 2.07

9.12 ± 2.13

8.59 ± 3.16

0.410

FBG (mmol/L)

8.21 ± 2.79

9.30 ± 5.16

7.57 ± 3.11c

0.030*

PBG0.5h

11.35 ± 3.23

11.83 ± 3.52

10.66 ± 3.96

0.165

PBG1h

14.79 ± 3.74

15.30 ± 4.93

13.75 ± 3.42

0.083

PBG2h

16.64 ± 4.05

16.71 ± 5.36

15.02 ± 3.82a, c

0.047*

PBG3h

14.83 ± 4.85

14.67 ± 4.57

13.25 ± 4.47

0.095

FINS (mIU/L)

11.8(5.01,18.0)

7.29(2.58,13.3)

7.75(3.27,12.9)

0.045*

INS0.5h

17.60(9.8,23.6)

12.45(5.50,24.65)

12.2(7.42,19.90)

0.174

INS1h

25.90(13.2,37.3)

16.15(9.11,36.30)

17.55(11.0,32.7)

0.120

INS2h

29.8(17.6,51.9)

19.8(10.95,46.97)

19.9(9.50,37.27)

0.077

INS3h

27.0(15.90,48.2)

18.35(8.88,37.65)

18.1(11.7,35.12)a

0.048*

FCP (ng/mL)

1.85(1.20,2.74)

1.47(0.89,2.31)

1.26(0.76,2.29)a

0.020*

CP0.5h

2.35(1.71,3.81)

1.89(1.27,3.04)

2.20(1.07,2.89)

0.070

CP1h

3.48(2.28,6.07)

2.65(1.65,4.41)

3.46(1.61,4.60)

0.110

CP2h

4.53(3.10,8.15)

4.17(2.49,6.27)

4.34(2.06,6.16)

0.237

CP3h

4.42(3.12,8.09)

3.73(2.31,5.37)

4.42(2.27,6.35)

0.062

GLA0 (pmol/L)

46.44 ± 19.45

46.91 ± 17.30

45.28 ± 17.76

0.865

GLA0.5h

43.76 ± 19.09

41.51 ± 15.82

35.38 ± 17.90a,c

0.018*

GLA1h

38.32 ± 17.03

35.80 ± 12.93

32.12 ± 12.80a

0.042*

GLA2h

35.12 ± 18.14

31.87 ± 13.34

30.41 ± 14.60

0.196

GLA3h

30.08 ± 16.03

28.28 ± 12.97

29.10 ± 13.72

0.766

HOMA-β

96.25 ± 183.46

73.72 ± 121.41

79.19 ± 106.41

0.626

HOMA-IR

4.76 ± 4.15

6.37 ± 13.21

4.00 ± 8.16

0.318

AUCglu3h

42.60 ±c10.56

43.66 ± 13.00

38.11 ± 11.22a,c

0.014*

AUCins3h

78.48 (44.12,123.72)

52.40 (26.21,105.52)

53.45 (29.05,93.65)a

0.024*

AUCcp3h

11.59 (7.76,19.68)

9.23 (6.13,13.46)

10.46 (5.14,15.17)

0.127

AUCgla3h

113.52 ± 45.21

105.85 ± 31.16

99.08 ± 36.75

0.090

Δcp0.5h

0.36 (− 0.01,0.80)

0.24 (0.06,0.62)

0.53 (0.14,1.06)a,c

0.030*

  1. Values with differing superscript letters (a, b, c) denoted statistically significant differences across the tertiles. The a or b represented a significant difference compared with T1 group, and the c represented a significant difference compared with T2 group. The * represented significant difference
  2. OCN Osteocalcin, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, ALT alanine aminotransferase, AST aspartate aminotransferase, UN urea nitrogen, Cr creatinine, SUA Serum uric acid, TG triglycerides, TC total cholesterol, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, HbA1c hemoglobin A1c, FBG fasting blood-glucose, PBG postprandial blood glucose, FINS fasting insulin, INS postprandial insulin, FCP fasting c-peptide, CP postprandial c-peptide, GLA glucagon, HOMA-β Homeostasis model of β cell function, HOMA-IR Homeostatic model of insulin resistance, AUCglu3h area under the curve of glucose, AUCins3h area under the curve of insulin, AUCgla3h area under the curve of glucagon, AUCcp3h area under the curve of c-peptide, Δcp0.5h early postprandial secretion function of islet β cells